Direct Flow Medical (Santa Rosa, CA) a development-stage medical device company focused on a percutaneous aortic tissue valve prosthesis, closed a $40M Series C financing. Participants include Johnson & Johnson Development Corp., Foundation Medical Partners, VantagePoint Venture Partners, ePlanet Ventures, EDF Ventures, New Leaf Venture Partners and Spray Venture Partners.